OBR Resources
- OBR Journal Articles
- OBR Daily eNews
- Recent Blog Entries
Feature Articles
Oncology Business Review is our industry trade journal with carefully developed, exclusive oncology industry content.
SUBSCRIBE to Oncology Business Review Journal Today!
The Ongoing Hopes and Challenges of Cancer Vaccines (Part 2 of 2)
March 1st
[ read article ]Managing the Health of Your Patients and Your Practice
March 1st
[ read article ]Risk-Sharing Schemes in Oncology—Future or Fad?
March 1st
[ read article ]A Perspective on Cancer Drug Pricing and Volume
March 1st
[ read article ]OBR Radar: Keeping an Eye on Projected Market Moving Events in the Oncology Pipeline
March 1st
[ read article ]ON-CURRENCES
March 1st
[ read article ]Read ALL Articles » | Read ARCHIVED Articles »
Top Headlines - Fri Mar 12, 2010
Featured Oncology News
BioSante Says Leukemia Vaccine Shows Promise In Study
(Reuters) Mar 11, 2010 - BioSante Pharmaceuticals Inc said a small study showed its GVAX leukemia vaccine may be able to reduce or eliminate the remaining cancer cells in some chronic myeloid leukemia (CML) patients taking cancer drug Gleevec, sending its shares up 22 percent.
read article »
Scientists Find Key to Hormone-Resistant Prostate Tumors
(BusinessWeek.com) Mar 10, 2010 - Though hormone therapy has proven useful in treating late-stage prostate cancer, it often results in the development of fatal secondary tumors that are resistant to such therapy.
read article »
Tumors May Respond to Extreme and Moderate Heat
(AACR) Mar 10, 2010 - Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
read press release »
Read ALL Featured Oncology News »
Oncology Clinical News
Scientists Identify MicroRNA as Possible Cause of Chemotherapy Resistance
(AACR) Mar 10, 2010 - Scientists may have uncovered a mechanism for resistance to paclitaxel in ovarian cancer, microRNA-31, suggesting a possible therapeutic target for overcoming chemotherapy resistance.
read press release »
Seaweed Extract May Hold Promise for Non-Hodgkin’s Lymphoma Treatment
(AACR) Mar 10, 2010 - Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held here March 7-10, 2010.
read press release »
Breast Cancer Incidence Among Iraqi Women Profiled
(AACR) Mar 10, 2010 - Breast cancer continues to rise in Iraq, and scientists have established the Iraqi National Cancer Research Program to better understand the underlying molecular and environmental causes in an effort to curb the incidence of cancer.
read press release »
Read ALL Oncology Clinical News »
Oncology Business and Policy News
Seattle Genetics Adds Patent to 2025
(Xconomy.com) Mar 11, 2010 - Seattle Genetics, the developer of antibody treatments for cancer, said today it has received a new patent which will extend its proprietary rights to its lead drug for Hodgkin’s disease until at least 2025.
read article »
Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC™
(Bavarian Nordic) Mar 9, 2010 – Bavarian Nordic A/S announced today that the company has received Scientific Advice from the European Medicines Agency and concluded an end of Phase II meeting with the US Food and Drug Administration (FDA) for the PROSTVAC™ programme.
read press release »
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R)
(Yahoo! Finance) Mar 11, 2010 - Caraco Pharmaceutical Laboratories, Ltd. has launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, which are therapeutically equivalent to Eloxatin® from Sanofi-Aventis, received approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
read article »
Read ALL Oncology Business and Policy News »
Broader Healthcare and Pharma News
Personalized Medicine Spurred by Medco’s Cost-Saving Gene Tests
(Bloomberg) Mar 11, 2010 - Medco Health Solutions Inc., the second-biggest U.S. manager of drug benefits, is encouraging doctors to use genetic tests to determine whether drugs will work for particular patients -- saving money and reducing harm caused when prescriptions are wrong.
read article »
Disease Cause Is Pinpointed With Genome
(New York Times) Mar 10, 2010 - Two research teams have independently decoded the entire genome of patients to find the exact genetic cause of their diseases. The approach may offer a new start in the so far disappointing effort to identify the genetic roots of major killers like heart disease, diabetes and Alzheimer’s.
read article (free registration required) »
FDA Will Review Fosamax, Boniva for Safety
(Wall Street Journal) Mar 11, 2010 - The Food and Drug Administration said Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures.
read article (paid subscription required) »
